Mental health: users of medications Argentina 2016-2028

The indicator 'Patients' in the mental health market in Argentina was forecast to continuously increase between 2024 and 2028 by in total 0.9 million users (+21.08 percent). After the twelfth consecutive increasing year, the indicator is estimated to reach 5.17 million users and therefore a new peak in 2028. Notably, the indicator 'Patients' of the mental health market was continuously increasing over the past years.

The Statista Market Insights cover a broad range of additional markets.

Number of users of mental health related medications in Argentina from 2016 to 2028 (in millions)

Characteristic	Users in millions
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

More information

Special properties

The data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war

Supplementary notes

Data provided by Statista Market Insights are estimates.

Mental health disorders are common illnesses found among people all over the world. These disorders are caused by a variety of genetic and environmental factors that cause imbalances in a person's physical and emotional behavior. Most mental health disorders can be treated with behavioral and psychotherapies. In some cases, however, medication is prescribed along with these treatments. The Mental Health market represents the market for the drugs that are used to treat various mild to serious mental health disorders. The market is divided into three markets that have been based on the disorders that are being treated. This includes depressive disorders, anxiety and related sleeping disorders, and different types of psychotic disorders.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, Johnson & Johnson, AbbVie, and Sumitomo pharma

Citation formats